THE COMMUNITY PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: F81740 | CANVEY ISLAND, SS8 0JA
Showing results 401-450 of 560
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 25 | 723 | £142 | +82.9% ▲ | |
| 25 | 210 | £223 | +140.6% ▲ | |
| Enoxaparin | 24 | 821 | £5.2K | +17.1% ▲ |
| Erythromycin ethylsuccinate | 24 | 3,800 | £333 | +2.8% ▲ |
| Indometacin | 24 | 1,848 | £119 | +52.5% ▲ |
| Mefenamic acid | 24 | 946 | £182 | -46.9% ▼ |
| Pilocarpine hydrochloride | 24 | 1,400 | £653 | +123.3% ▲ |
| 24 | 307 | £328 | -25.8% ▼ | |
| Fesoterodine fumarate | 23 | 1,148 | £95 | -41.7% ▼ |
| Meloxicam | 23 | 650 | £18 | -65.2% ▼ |
| 23 | 210 | £439 | -41.5% ▼ | |
| 23 | 120 | £345 | -4.9% ▼ | |
| Tiotropium bromide/olodaterol | 22 | 22 | £680 | -64.1% ▼ |
| Imipramine hydrochloride | 22 | 980 | £37 | -13.7% ▼ |
| Orlistat | 22 | 1,848 | £467 | -73.3% ▼ |
| Estradiol valerate | 22 | 2,408 | £201 | +12.6% ▲ |
| Powder preterm infant formula (0913111) | 22 | 45.6K | £736 | +38.1% ▲ |
| Powder thickener - gum based (0913161) | 22 | 7,482 | £416 | -70.7% ▼ |
| 22 | 280 | £616 | -50.0% ▼ | |
| 22 | 840 | £573 | +97.8% ▲ | |
| Terbutaline sulphate | 21 | 21 | £166 | -61.3% ▼ |
| Guanfacine | 21 | 672 | £1.4K | -18.3% ▼ |
| 21 | 253 | £570 | -0.7% vs avg | |
| 21 | 24 | £110 | -48.4% ▼ | |
| 21 | 2,712 | £3.1K | +277.7% ▲ | |
| Olmesartan medoxomil/amlodipine | 20 | 952 | £548 | +51.6% ▲ |
| Colestyramine | 20 | 1,180 | £416 | -30.6% ▼ |
| Phenobarbital | 20 | 1,792 | £53 | -35.0% ▼ |
| Timolol and brimonidine | 20 | 195 | £401 | +42.5% ▲ |
| Metronidazole | 20 | 910 | £235 | -46.8% ▼ |
| 20 | 220 | £387 | -39.1% ▼ | |
| Midodrine hydrochloride | 19 | 1,758 | £378 | -61.0% ▼ |
| Temazepam | 19 | 644 | £567 | -66.8% ▼ |
| Lacosamide | 19 | 1,932 | £258 | -64.6% ▼ |
| Methenamine hippurate | 19 | 1,136 | £315 | -79.1% ▼ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 19 | 103.5K | £2.1K | -50.2% ▼ |
| Powder amino acid formula (0913107) | 19 | 49.2K | £3.1K | -42.5% ▼ |
| Lidocaine | 19 | 570 | £63 | +301.5% ▲ |
| Heparinoid | 19 | 1,050 | £80 | +45.7% ▲ |
| 19 | 155 | £337 | +39.3% ▲ | |
| 19 | 840 | £2.6K | +61.4% ▲ | |
| Methyldopa | 18 | 2,568 | £545 | +5.7% ▲ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 18 | 756 | £435 | +13.8% ▲ |
| Dosulepin hydrochloride | 18 | 2,136 | £463 | -68.2% ▼ |
| Promethazine teoclate | 18 | 910 | £134 | +79.8% ▲ |
| Denosumab | 18 | 18 | £3.3K | -33.9% ▼ |
| Ferrous gluconate | 18 | 1,946 | £54 | -62.4% ▼ |
| Diclofenac sodium | 18 | 201 | £56 | -64.5% ▼ |
| Terbinafine hydrochloride | 18 | 285 | £63 | -51.5% ▼ |
| 18 | 680 | £226 | -39.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.